Table 3.

Liver index measurements from the rats at the end of the 8-week study.

Treatment	Body weight (gm)	Liver weight (gm)	Liver index (LW/BW %)
Group 1 (normal rats)	347 ± 5.04	9.70 ± 0.16	2.79 ± 0.21
Group 2 (rats with cirrhosis)	183 ± 2.32	9.44 ± 0.60	5.18 ± 0.06**
Group 3 (silymarin-treated rats)	347 ± 3.58	10.28 ± 0.66	2.97 ± 0.35*
Group 4 (treatment with the BR extract at 250 mg/kg dose)	255 ± 2.91	10.03 ± 0.46	3.93 ± 0.44*
Group 5 (treatment with the BR extract at 500 mg/kg dose)	376 ± 5.67	9.71 ± 0.71	2.59 ± 0.36*

Data were expressed as Mean ± SEM. Means between the silymarin-treated Group 3, low-dose BR-treated Group 4, and high-dose BR-treated Group 5 had significant differences when compared with the cirrhosis control Group 2 with *P < 0.001 and compared with the normal control Group 1 with **P < 0.001.